Your cart:$ 0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Sevelamer hydrochloride - Accupril, Actos, Renagel

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Accupril

Generic Accupril

Quinapril Hydrochloride 5/10/20mg

Generic Accupril is used for lowering high blood pressure and managing heart failure. It is used alone or with other medicines.

More info »
$ 0.74 Buy now!
Actos

Generic Actos

Pioglitazone Hydrochloride 15/30mg

Generic Actos is used for treating type 2 diabetes in certain patients. It is used along with diet and exercise.

More info »
$ 0.67 Buy now!
Renagel

Generic Renagel

Sevelamer Hydrochloride 400/800mg

Generic Renagel is used for reducing the amount of phosphorus in the blood in patients with chronic kidney disease who are on dialysis.

More info »
$ 3.65 Buy now!
Country, language and currency
Social bookmarks:
Testimonials
The parcel has arrived today, thanks for your prompt delivery. The extra pack enclosed to the order is greatly appreciated. - Best regards, U Geilert
Read more »
Special Offer!

Keryx Partners In Japan See Positive Results From Zerenex - Wall Street Journal
Keryx Partners In Japan See Positive Results From ZerenexWall Street JournalIn a Phase 3 study, Keryx partners Japan Tobacco Inc
Novel Iron-Based Phosphate Binder Effective, Well-Tolerated - Renal and Urology News
Novel Iron-Based Phosphate Binder Effective, Well-ToleratedRenal and Urology NewsIn the trial, which compared PA21 with sevelamer hydrochloride, 152 HD patients received a fixed-dose regimen of either PA21 (1
Japan Tobacco, Torii report positive top-line results from Phase III Zerenex study - Pharmaceutical Business Review
Japan Tobacco, Torii report positive top-line results from Phase III Zerenex studyPharmaceutical Business ReviewThe primary endpoint of efficacy has met non-inferiority to sevelamer hydrochloride in the top-line results, which evaluated the change of serum phosphorus from baseline
Keryx Announces Positive Top-Line Results from Phase 3 Study; Medgenics Files ... - Proactive Investors USA & Canada
Keryx Announces Positive Top-Line Results from Phase 3 Study; Medgenics Files
Keryx Announces Positive Top-Line Results from Phase 3 Study; Medgenics Files ... - BioMedReports (subscription)
Keryx Announces Positive Top-Line Results from Phase 3 Study; Medgenics Files
bookmark Bookmark this site
Subscribe to the News